Pituitary Adenoma Clinical Trial
Official title:
Characteristics of Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
Glucose fluctuations present not only in patients with diabetes mellitus but also in subjects with normal glucose tolerance or impaired glucose regulation. People with Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome are at risk of impaired glucose metabolism. Glycemic variability is poorly studied in the nondiabetic individuals. The aim of the study is to investigate the characteristics of glucose fluctuations in the newly diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome individuals.
Glucose fluctuations present not only in patients with diabetes mellitus but also in subjects
with normal glucose tolerance or impaired glucose regulation. Compared with traditional
monitoring methods, continuous glucose monitoring system(CGMS) techniques provides a much
more detailed understanding of shifting blood glucose levels throughout the day.It is
considered reliable to evaluate glucose variability not only in patients with diabetes but
also in nondiabetic individuals.
People with Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome are at risk of
impaired glucose metabolism and developing diabetes mellitus.Some researchers have shown that
15-30% Growth Hormone-Secreting Pituitary Adenoma are suffering from diabetes, 15-36%
impaired glucose regulation. The rate of Cushing Syndrome individuals is 10-30% and 40-45%
separately.
Glycemic variability is poorly studied in the nondiabetic individuals and has not been
studied in the newly diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing
Syndrome individuals. In this study CGM was used to dynamically monitor patients being newly
diagnosed with Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04081701 -
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
|
Phase 4 | |
Completed |
NCT01689064 -
Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection
|
N/A | |
Recruiting |
NCT04611685 -
Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas
|
N/A | |
Completed |
NCT04212793 -
Detection of PitNET Tissue During TSS Using Bevacizumab-800CW
|
Phase 1 | |
Recruiting |
NCT02709863 -
Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests
|
N/A | |
Completed |
NCT01465672 -
Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
|
N/A | |
Terminated |
NCT00798057 -
Proton Radiation Therapy for Pituitary Adenoma
|
N/A | |
Completed |
NCT01504399 -
Rhinological Outcomes in Endonasal Pituitary Surgery
|
||
Recruiting |
NCT01556230 -
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
|
||
Completed |
NCT04074642 -
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
|
N/A | |
Recruiting |
NCT04621565 -
Hydrocortisone Use During Peri-operation for Pituitary Adenomas
|
N/A | |
Completed |
NCT04076046 -
Multicentric Prospective Validation of the Zurich Pituitary Score
|
||
Not yet recruiting |
NCT03714763 -
Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)
|
N/A | |
Recruiting |
NCT05822817 -
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
|
Phase 4 | |
Recruiting |
NCT03164148 -
Heart Rate Variability (HRV) in Pituitary Adenoma
|
N/A | |
Completed |
NCT04284605 -
Effects Exercise Training in Patients With Pituitary Adenoma
|
N/A | |
Terminated |
NCT03515603 -
Endocrine Outcome of Surgery for Pituitary Adenoma
|
N/A | |
Not yet recruiting |
NCT04863456 -
Efficiency and Safety of Different Treatment Strategies in Adults With Pituitary Adenomas With Hypothalamic Involvement
|
N/A | |
Active, not recruiting |
NCT03465618 -
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
|
Phase 1 | |
Completed |
NCT02727686 -
Post-Operative Water Load Following Transsphenoidal Pituitary Surgery
|
N/A |